Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-980
Closed -$56K 365
2022
Q3
$56K Hold
980
﹤0.01% 499
2022
Q2
$46K Hold
980
﹤0.01% 527
2022
Q1
$56K Hold
980
﹤0.01% 502
2021
Q4
$52K Hold
980
﹤0.01% 523
2021
Q3
$49K Hold
980
﹤0.01% 503
2021
Q2
$58K Hold
980
﹤0.01% 509
2021
Q1
$64K Hold
980
﹤0.01% 425
2020
Q4
$54K Hold
980
﹤0.01% 368
2020
Q3
$43K Hold
980
﹤0.01% 379
2020
Q2
$41K Hold
980
﹤0.01% 370
2020
Q1
$38.9K Sell
980
-174
-15% -$7.36K 0.01% 362
2019
Q4
$51.4K Sell
1,154
-161
-12% -$6.19K 0.01% 404
2019
Q3
$45K Buy
+1,315
New +$45.5K 0.01% 489

Other funds holding ACA

Evoke Wealth's ACA Position: Q4 2022 in Review

Evoke Wealth sold out of Arcosa (ACA) in Q4 2022, closing a stake of 980 shares — an estimated $56K sold.

Evoke Wealth first reported a position in ACA in Q3 2019 and held it in 13 quarters. The position peaked at $64K in Q1 2021. 267 funds tracked by Wall St. Rank hold ACA as of Q4 2022.

  • Evoke Wealth reported no remaining Arcosa position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 980 Arcosa shares in Q4 2022, an estimated $56K.
  • Evoke Wealth first reported a position in Arcosa in Q3 2019 and held it in 13 quarters.
  • Evoke Wealth's Arcosa position peaked at $64K in Q1 2021.
  • 267 funds tracked by Wall St. Rank held Arcosa as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.